Cancer News and Research

Latest Cancer News and Research

Harbor BioSciences granted US patent for Triolex metabolic disease and anti-inflammation drug candidate

Harbor BioSciences, Inc. today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark Office which covers its lead metabolic disease and anti-inflammation drug candidate Triolex (HE3286). The patent claims cover compounds including Triolex and formulations that contain the drug or the other claimed compounds.

20 Sep 2010

Celldex commences CDX-011 Phase 2b trial in advanced breast cancer patients expressing GPNMB

Celldex Therapeutics, Inc. today announced that the first patient has been treated in a randomized Phase 2b study of the Company's CDX-011 (glembatumumab vedotin) antibody drug conjugate in glycoprotein NMB (GPNMB) expressing advanced, refractory breast cancer patients. CDX-011 targets the protein GPNMB, which is over expressed in a variety of cancers including breast cancer, melanoma, and brain tumors.

20 Sep 2010

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.

20 Sep 2010

Micromet initiates MT103 phase 2 trial in adult ALL patients

Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.

20 Sep 2010

Chronix Biomedical completes Series E financing

Chronix Biomedical today announced that it has completed a Series E financing that raised $1.8 million from existing and new investors. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. Chronix's serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.

20 Sep 2010

Myrexis releases MPC-9528 cancer metabolism inhibitor preclinical study results

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.

20 Sep 2010

Cord Blood America acquires controlling interest of Biocordcell Argentina

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that it has purchased controlling interest, 50.1 percent, of Biocordcell Argentina S.A. (BioCells, Inc.).

20 Sep 2010

Warning on Australian clinics offering safe alternatives to mammograms

Experts have warned that some private clinics that are offering safe alternatives to mammograms as breast cancer screening are doing more harm than good. It is seen that clinics offering services like botox, liposuction and spray tans are increasingly providing breast cancer screening that uses thermal imaging and “electrical impedance” technology. These methods are being used on women as young as 20, with claims they can detect cancer years earlier than mammograms.

20 Sep 2010

Researchers discover HIV-1 resists AZT drug

Rutgers researchers have discovered how HIV-1, the virus that causes AIDS, resists AZT, a drug widely used to treat AIDS. The scientists, who report their findings in Nature Structural & Molecular Biology, believe their discovery helps researchers understand how important anti-AIDS treatments can fail and could help AIDS researchers develop more effective treatment for the disease.

20 Sep 2010

BRCA1 gene mutation increases breast cancer risk: Research

Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic researchers show that some of those persons may possess additional genetic variants that modify their risk. These new findings enhancing individualized medicine appear in the current Nature Genetics.

20 Sep 2010

Scientists develop microscopic gas-filled spheres of silica to locate breast cancers

A new material could help surgeons more accurately locate breast cancers, reduce the need for second surgeries and minimize pre-surgical discomfort for patients. Microscopic gas-filled spheres of silica, a porous glass, can mark the location of early-stage tumors to show their position using ultrasound imaging in the operating room.

20 Sep 2010

Scientists discover new genetic variants, pave way for early detection of ovarian cancer

An international consortium of scientists has discovered new genetic variants in five regions of the genome that affect the risk of ovarian cancer in the general population, according to two separate studies published today (Sunday), online in Nature Genetics.

20 Sep 2010

Immunotherapy accepted for coverage in MEDLINE®

Future Medicine Ltd announced today that its journal Immunotherapy (ISSN 1750-743X) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine, MEDLINE® (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

19 Sep 2010

ABC Entertainment, CafePress launch official Dancing with the Stars team t-shirts for Stand Up To Cancer

ABC Entertainment Group and CafePress today announce the launch of official Dancing with the Stars team t-shirts with sales benefiting Stand Up To Cancer.

18 Sep 2010

LUHS launches Pink Glove Dance Video Sequel to raise breast cancer awareness

Loyola University Health System (LUHS) nurses may be part of the next YouTube craze thanks to their Pink Glove Dance Video Sequel, which launches today. The video is the second installment in a series of vignettes to raise awareness for breast cancer.

18 Sep 2010

The John Theurer Cancer Center to host Second Annual Celebrating Life and Liberty cancer survivor event

The John Theurer Cancer Center at Hackensack University Medical Center announced that thousands of cancer survivors and caregivers will celebrate life, liberty and new beginnings with the ultimate symbol of freedom close by the Statue of Liberty.

18 Sep 2010

Hastings Center Report examines ethical controversies over use of personalized medicine

As government support for personalized medicine grows, a consumer advocate, a patient, and bioethicists explore ethical controversies. Direct-to-consumer genetic tests, privacy, targeted cancer therapies, and Henrietta Lacks are among topics in a special issue of the Hastings center Report

18 Sep 2010

Diverse coalition urges California Governor to sign bill to provide health coverage for smoking cessation treatments

A large and unusually diverse of group of interests have come together to urge Governor Schwarzenegger to sign a key health related measure, Senate Bill 220 (Yee, D-San Francisco), which would provide health coverage of smoking cessation treatments and services.

18 Sep 2010

Sutter Home Family Vineyards renews annual Sutter Home for Hope program

Sutter Home Family Vineyards today announced the renewal of its annual Sutter Home for Hope program. Since 2001, Sutter Home has been committed to supporting breast cancer research through the consumer-driven Capsules for Hope program and has donated more than $800,000 toward breast cancer awareness.

18 Sep 2010

CNSI, MESA+ collaborate to expand nanotechnology projects

The California NanoSystems Institute at UCLA and the MESA+ Institute of Nanotechnology at the University of Twente in the Netherlands have signed a memorandum of understanding to use their combined intellectual and physical resources to collaborate on projects that apply nanotechnology to problems of global concern in health and the environment.

18 Sep 2010

Cancer News and Research

Latest Cancer News and Research

Harbor BioSciences granted US patent for Triolex metabolic disease and anti-inflammation drug candidate

Celldex commences CDX-011 Phase 2b trial in advanced breast cancer patients expressing GPNMB

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Micromet initiates MT103 phase 2 trial in adult ALL patients

Chronix Biomedical completes Series E financing

Myrexis releases MPC-9528 cancer metabolism inhibitor preclinical study results

Cord Blood America acquires controlling interest of Biocordcell Argentina

Warning on Australian clinics offering safe alternatives to mammograms

Researchers discover HIV-1 resists AZT drug

BRCA1 gene mutation increases breast cancer risk: Research

Scientists develop microscopic gas-filled spheres of silica to locate breast cancers

Scientists discover new genetic variants, pave way for early detection of ovarian cancer

Immunotherapy accepted for coverage in MEDLINE®

ABC Entertainment, CafePress launch official Dancing with the Stars team t-shirts for Stand Up To Cancer

LUHS launches Pink Glove Dance Video Sequel to raise breast cancer awareness

The John Theurer Cancer Center to host Second Annual Celebrating Life and Liberty cancer survivor event

Hastings Center Report examines ethical controversies over use of personalized medicine

Diverse coalition urges California Governor to sign bill to provide health coverage for smoking cessation treatments

Sutter Home Family Vineyards renews annual Sutter Home for Hope program

CNSI, MESA+ collaborate to expand nanotechnology projects

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in